著名医疗保健数据和分析公司艾昆纬(IQV)今日盘前大涨5.63%，主要是受到公司最新一季度业绩优于华尔街预期的推动。
艾昆纬公布2024年第四季度调整后每股收益为3.12美元，超过分析师平均预期的3.11美元。同时公司第四季度营收达到39.58亿美元，也高于39.35亿美元的预期。
数据显示，公司技术和分析解决方案部门的强劲表现是驱动业绩超预期的主要原因。由于过去两年药物批准数量增加，推动了制药客户的商业支出回升，推动了该部门收入增长。该部门向制药和消费者健康公司提供信息和技术服务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.